EZ SPERSE Trademark

Trademark Overview

On Thursday, May 28, 2015, a trademark application was filed for EZ SPERSE with the United States Patent and Trademark Office. The USPTO has given the EZ SPERSE trademark a serial number of 79170674. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, October 7, 2022. This trademark is owned by Dexcel Pharma Technologies Ltd.. The EZ SPERSE trademark is filed in the Pharmaceutical Products category with the following description:

Orally disintegrating tablets and orally disintegrating medicaments for the treatment of genetic, cardiovascular, central nervous system, endocrine, gastrointestinal, hepatic, biliary, immunological, allergic, pulmonary, dermatological, infectious, inflammatory, menopausal, nutritional, metabolic, diabetes, autoimmune, musculoskeletal, connective tissue, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, erectile dysfunction, sexual dysfunction, gynecology, obstetric, pediatric, hematologic, oncological, fungal and viral diseases and disorders
ez sperse

General Information

Serial Number79170674
Word MarkEZ SPERSE
Filing DateThursday, May 28, 2015
Status709 - CANCELLED - SECTION 71
Status DateFriday, October 7, 2022
Registration Number4920249
Registration DateTuesday, March 22, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 5, 2016

Trademark Statements

Goods and ServicesOrally disintegrating tablets and orally disintegrating medicaments for the treatment of genetic, cardiovascular, central nervous system, endocrine, gastrointestinal, hepatic, biliary, immunological, allergic, pulmonary, dermatological, infectious, inflammatory, menopausal, nutritional, metabolic, diabetes, autoimmune, musculoskeletal, connective tissue, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, erectile dysfunction, sexual dysfunction, gynecology, obstetric, pediatric, hematologic, oncological, fungal and viral diseases and disorders
Pseudo MarkEASY SPERSE

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, October 7, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDexcel Pharma Technologies Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIL
Party NameDexcel Pharma Technologies Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIL
Party NameDexcel Pharma Technologies Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIL

Trademark Events

Event DateEvent Description
Monday, July 31, 2023TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, July 12, 2023TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Tuesday, July 11, 2023INVALIDATION PROCESSED
Wednesday, June 7, 2023TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, October 7, 2022CANCELLED SECTION 71
Monday, March 22, 2021COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Monday, August 7, 2017LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Friday, July 7, 2017LIMITATION OF GOODS RECEIVED FROM IB
Friday, July 15, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, June 23, 2016FINAL DISPOSITION NOTICE SENT TO IB
Thursday, June 23, 2016FINAL DISPOSITION PROCESSED
Wednesday, June 22, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 22, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, January 5, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 5, 2016PUBLISHED FOR OPPOSITION
Monday, January 4, 2016NOTIFICATION PROCESSED BY IB
Wednesday, December 16, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 16, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 16, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, November 28, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 12, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 12, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 12, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 2, 2015REFUSAL PROCESSED BY IB
Monday, September 14, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, September 14, 2015REFUSAL PROCESSED BY MPU
Saturday, September 12, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, September 11, 2015NON-FINAL ACTION WRITTEN
Wednesday, September 9, 2015ASSIGNED TO EXAMINER
Tuesday, August 25, 2015APPLICATION FILING RECEIPT MAILED
Wednesday, August 19, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 13, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

sperse dysfunction orally disintegrating respiratory urogenital urological psychiatric neurological musculoskeletal connective